What DAC does: the albumin binding strategy The Drug Affinity Complex is a maleimidopropionic acid (MPA) linker attached to the peptide's lysine residue
Major Ingredients Water, Methylpropanediol, Glycerin, Niacinamide, 1,2-Hexanediol, Hydroxyacetophenone, Allantoin, Polyglyceryl-10 Laurate, Panthenol, Adenosine, Disodium EDTA, Xylitol, Arbutin, Sodium Hyaluronate, Butylene Glycol, Hydrolyzed Hyaluronic Acid , Cyanocobalamin, Gluconolactone, Ascorbyl Glucoside, Glutathione, Fragrance Ingredients subject to change at manufacturer's discretion
10.3390/ijms21051725 41 JensterleM.RizzoM.HaluzkM.JaneA
Reprod Health 18 , 207 (2021)
Nucleic Acids 34 , 102040 (2023)
However, a recent consensus report addressed the growing interest in GLP-1 receptor agonists as an adjunctive therapy for T1D and their potential to improve glycemic and metabolic outcomes without increasing the risk of severe hypoglycemia or diabetic ketoacidosis. Lets examine GLP-1 therapies and SGLT inhibitors and consider how drugs like Ozempic may one day help people with type 1 diabetes